Objective To investigate the effects of cordycepin on oxidative stress and expression of caspase-3 and P53 in brain tissue of rats with middle cerebral artery occlusion (MCAO). Methods First, rats in the drug-administered group were intraperitoneally injected with 5, 10, and 20 mg/kg of cordycepin for 10 days. Then, the middle cerebral artery occlusion model was prepared by modified Zea Longa suture method. The neurological function was scored by blind method after the MCAO was prepared for 24h. The brain water content was detected by weighing method. The pathological damage of brain tissue was observed by HE staining and Tunnel staining was used to detect the apoptosis of brain cell. The expression of Bcl-2, Bax, Caspase-3 and p53 mRNA was detected by RT-PCR. The protein expression of Bcl-2, Bax and Caspase were detected by Western blotting. The expression of SOD, MDA, GSH levels were detected by kit. Results Compared with the MCAO group, the neurological function score, the brain water content, the cell damage and the apoptosis rate of the drug-administered group significantly reduced. The Bax mRNA and protein expression, the expression of Caspase-3 and p53 mRNA and protein expression significantly down-regulated, and the Bcl-2 mRNA and protein expression significantly up-regulated. The content of MDA decreased, the content of SOD and GSH increased significantly. With the increasing of cordycepin, the effects were much more effective. Conclusions Cordycepin can relieve neurological dysfunction caused by focal cerebral ischemia in the middle cerebral artery and reduce brain water content caused by cerebral ischemia, and can also inhibit apoptosis and oxidative stress in rats with focal cerebral ischemia, which slows the damage caused by focal cerebral ischemia in the middle cerebral artery.
Key words
Cordycepin; /
/
Middle cerebral artery focal cerebral ischemia; /
/
Oxidative stress; /
/
Caspase-3; /
/
P53
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Fu L, Huang L, Cao C, et al. Inhibition of amp-activated protein kinase alleviates focal cerebral ischemia injury in mice: Interference with mtor and autophagy[J]. Brain Res, 2016, 1650(1): 103-111.
[2] Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke, 1989, 20(1): 84-91.
[3] Tuli HS, Sharma AK, Sandhu SS, et al. Cordycepin: A bioactive metabolite with therapeutic potential[J]. Life Sci, 2013, 93(23): 863-869.
[4] Cheng Z, He W, Zhou X, et al. Cordycepin protects against cerebral ischemia/reperfusion injury in vivo and in vitro[J]. Eur J Pharmacol, 2017, 664(1-3): 20-28.
[5] Maleki SN, Aboutaleb N, Souri F. Berberine confers neuroprotection in coping with focal cerebral ischemia by targeting inflammatory cytokines[J]. J Chem Neuroanat, 2018, 87(2): 54-59.
[6] Jeong JW, Jin CY, Kim GY, et al. Anti-inflammatory effects of cordycepin via suppression of inflammatory mediators in BV2 microglial cells[J]. Int Immunopharmacol, 2018, 10(12): 1580-1586.
[7] Liu PK, Grossman RG, Hsu CY, et al. Ischemic injury and faulty gene transcripts in the brain[J]. Trends Neurosci, 2001, 24(10): 581-588.
[8] Na JY, Song K, Lee JW, et al. Pretreatment of 6-shogaol attenuates oxidative stress and inflammation in middle cerebral artery occlusion-induced mice[J]. Eur J Pharmacol, 2016, 788: 241-247.
[9] Lei J, Wei Y, Song P, et al. Cordycepin inhibits lps-induced acute lung injury by inhibiting inflammation and oxidative stress[J]. Eur J Pharmacol, 2018, 818(2): 110-114.
[10]Nan W, Zhonghang X, Keyan C, et al. Epigallocatechin-3-gallate reduces neuronal apoptosis in rats after middle cerebral artery occlusion injury via pi3k/akt/enos signaling pathway[J]. Biomed Res Int, 2018, 2018(5): 6473580.
[11] Liu J, Jiang X, Zhang Q, et al. Neuroprotective effects of kukoamine a against cerebral ischemia via antioxidant and inactivation of apoptosis pathway[J]. Neurochem Int, 2017, 107(7): 191-197.
[12]Joo JC, Hwang JH, Jo E, et al. Cordycepin induces apoptosis by caveolin-1-mediated JNK regulation of Foxo3a in human lung adenocarcinoma[J]. Oncotarget, 2017, 8(7): 12211-12224.
[13]Hwang JH, Joo JC, Kim DJ, et al. Cordycepin promotes apoptosis by modulating the erk-jnk signaling pathway via DUSP5 in renal cancer cells[J]. Am J Cancer Res, 2016, 6(8): 1758-1771.
[14]Shao LW, Huang LH, Yan S, et al. Cordycepin induces apoptosis in human liver cancer HEPG2 cells through extrinsic and intrinsic signaling pathways[J]. Oncol Lett, 2016, 12(2): 995-1000.
[15]Olatunji OJ, Feng Y, Olatunji OO, et al. Cordycepin protects PC12 cells against 6-hydroxydopamine induced neurotoxicity via its antioxidant properties[J]. Biomed Pharmacother, 2017, 81(7): 7-14.
